发明名称 Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias
摘要 Methods for assessing a pathological condition in a subject include measuring one or more markers where a difference is indicative of acute lymphoblastic leukemia (ALL) or a predisposition to ALL, uses and compositions are disclosed.
申请公布号 US9139830(B2) 申请公布日期 2015.09.22
申请号 US201313916699 申请日期 2013.06.13
申请人 The Ohio State University Research Foundation 发明人 Croce Carlo M.
分类号 C12N15/11;C12N15/113;G01N33/574;C12Q1/68;G01N33/50 主分类号 C12N15/11
代理机构 MacMillan, Sobanski & Todd, LLC 代理人 MacMillan, Sobanski & Todd, LLC
主权项 1. A method to interfere with an acute lymphoblastic leukemia (ALL) response signaling pathway in at least one leukemic cell producing an ALL1/AF9 chimeric fusion protein, wherein the method comprises: administering, to at least one K562 leukemic cell, 5-iodotubericidin and an ALL1/AF9-specific siRNA consisting of “SEMj” which suppresses expression of an ALL1/AF9 chimeric fusion protein, thereby interfering with an acute lymphoblastic leukemia (ALL) response signaling pathway.
地址 Columbus OH US